|
|
|
|
|
|
|
|
Session Chairs: Laura Manuelidis and Pasquale Ferrante |
8:00 am |
W. Ian Lipkin (Plenary)
Columbia University Medical Center, New York, NY, USA |
Microbe hunting |
|
|
|
8:30 am |
Beatriz Parra
Universidad del Valle, Cali, Colombia |
Systemic reactivation of Epstein Bar Virus (EBV) correlates with the magnitude of parenchymal brain abnormalities in AIDS-associated CNS opportunistic infections |
|
|
|
8:45 am |
Francesca Peruzzi
Louisiana State University Health Sciences Center, New Orleans, LA, USA |
CSF microRNAs in HIV-associated neurological disorders |
|
|
|
9:00 am |
Maria Chiara Monaco
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA |
CD34+ hematopoietic progenitor cells are a reservoir for JC virus in CD34+ natalizumab-treated MS patients |
|
|
|
|
|
Introduction by Richard Johnson |
|
Peter G. E. Kennedy
University of Glasgow, Southern General Hospital, Glasgow, UK |
The enigma of varicella-zoster virus latency |
|
|
|
|
|
|
|
|
Session Chairs: Antonina Dolei and Robert Fujinami |
10:05 am |
Bradley Hollidge
Graduate Student, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA |
Recombinant La Crosse viruses with mutations in the fusion peptide region are less neuroinvasive, but remain neurotoxic |
|
|
|
10:20 am |
Camilla Carloni
Graduate Student, University of Milan, Milan, Italy |
JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy |
|
|
|
10:35 am
|
Manohar Mutnal
Postdoctoral Research Associate, University of Minnesota, Minneapolis, MN, USA |
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus |
|
|
|
|
|
Session Chairs: Dianne Langford and Rick Meeker |
10:50 am |
Thomas Wisniewski (Plenary)
NYU Pearl Barlow Center for Memory Evaluation and Treatment, New York, NY, USA |
Infectious neurodegenerative disorders |
|
|
|
11:20 am |
Michal Toborek
University of Miami Miller School of Medicine, Miami, FL, USA |
Interactions of HIV-1 with amyloid beta peptide at the blood-brain barrier level |
|
|
|
11:35 am |
Shao-Jun Tang
University of Texas Medical Branch, Galveston, TX, USA |
Wnt signaling and NeuroAIDS |
|
|
|
11:50 am |
Mady Hornig
Columbia University Mailman School of Public Health, New York, NY, USA |
Hippocampal dysgenesis in a model of gestational virus infection |
|
|
|
|
|
|
|
|
Session Chairs: Brian Wigdahl and Jay Rappaport |
1:35 pm |
David M. Stoff
National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA
|
NIMH research training in NeuroAIDS |
|
|
|
1:50 pm |
Sarah Gheuens
Postdoctoral Fellow, Beth Israel Deaconess Medical Center – Harvard Medical School, Boston, MA, USA |
Metabolic profile of Progressive Multifocal Leukoencephalopathy lesions in patients with and without Immune Reconstitution Inflammatory Syndrome |
|
|
|
2:05 pm |
Sarah Beltrami
Graduate Student, Temple University School of Medicine, Philadelphia, PA, USA |
Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glial cells |
|
|
|
2:20 pm |
Kimberly Williams
Graduate Student, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA |
Suppression of HIV-associated macrophage neurotoxic activity by neurotrophin receptor stimulation |
|
|
|
2:35 pm |
Anna Abt
Graduate Student, Drexel University College of Medicine, Philadelphia, PA, USA |
Effects of morphine on ferritin subunits and resulting inhibition of CXCR4-mediated neuroprotection |
|
|
|
|
|
|
|
|
Introduction by Shilpa Buch |
|
Ashley T. Haase
University of Minnesota Medical School, Minneapolis, MN, USA |
How the live attenuated monkey vaccines in which we both were interested might work |
|
|
|
|
|
Session Chairs: Rosemarie Booze and Steven Jacobson |
3:40 pm |
Kenneth Williams (Plenary)
Boston College, Chestnut Hill, MA, USA |
Myeloid regulation of inflammation in SIV and HIV infection |
|
|
|
4:10 pm |
Mineki Saito
University of the Ryukyus, Okinawa, Japan |
Complete prevention of HTLV-1 infection in humanized mice by a neutralizing monoclonal antibody to envelope gp46 |
|
|
|
4:25 pm |
Susan Westmoreland
New England Primate Research Center, Southborough, MA, USA |
Giant cell encephalitis in R5 SHIV-infected rhesus macaques |
|
|
|
4:40 pm |
Chen Sabrina Tan
Beth Israel Deaconess Medical Center, Boston, MA, USA |
JC virus infection in a humanized mouse model |
|
|
|
|
|